Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action | Charles Explorer

Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action

Publication at Faculty of Science |

2004

Abstract

Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action

Keywords

ANTICANCER DRUG ELLIPTICINE DNA ADDUCTS IN VIVO 32P-postlabeling cytochrome P450 (CYP) CYP1A1/2

People